University of California Los Angeles — Los Angeles, California

Public research footprint of University of California Los Angeles, compiled from the ClinicalTrials.gov public registry.

1,328

Registered studies

454

Active

261

Recruiting now

632

Completed

191

Stopped or withdrawn

Most-studied conditions

Diffuse Large B Cell Lymphoma (DLBCL) · Non-Hodgkin Lymphoma Refractory/ Relapsed · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung…

Recently updated registry entries

NCT03996239 — Researching the Effect of Aerobic Exercise on Cancer (Active Not Recruiting)
NCT05654922 — Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in… (Recruiting)
NCT05788536 — A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California Los Angeles?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.